[ad_1] L'astéroïde cylindrique, baptisé Asteroid 2018 VA2, approchera la Terre peu après 10h01 GMT (UTC) le vendredi 10 novembre. La NASA s'attend à ce que l'astéroïde vole à une vitesse vertigineuse et …
Read More »
[ad_1] MUNICH: Roche's entrectinib-based cancer pill has been shown to reduce tumors in 57% of patients in a uniquely identifiable group by genetic profile, Swiss drug maker challenging Bayer's alliance with Loxo …
Read More »
[ad_1] A year ago, data from the Lorelei trial on the taselisib aspirator, Roche's PI3K inhibitor, finally failed and the project was abandoned. Today, at Esmo, Novartis has unveiled the full results …
Read More »
[ad_1] MUNICH (Reuters) – Roche's entrectinib-based cancer pill has been shown to reduce tumors in 57% of patients in a group that can only be identified by genetic profile, with the Swiss …
Read More »
[ad_1] ZURICH / MUNICH (Reuters) – A Roche immunotherapy cocktail has helped slow down a type of aggressive breast cancer, while new treatments have proven elusive, offering positive news for the Swiss …
Read More »
[ad_1] Selon la Central Michigan University, un rocher de 22 livres qui a ouvert une porte au Michigan pendant des décennies s’avère être une météorite évaluée à 100 000 dollars. Par Amanda …
Read More »
[ad_1] Une roche qui a été utilisée comme une porte dans une ferme du Michigan pendant des décennies a été identifiée comme une météorite valant 100 000 $. MOUNT PLEASANT, Mich. – …
Read More »
[ad_1] Results from a Phase 3 clinical trial, CAPSTONE-2, evaluating Genentech's Balboxavir Marboxil at Roche (OTCQX: RHHBY) in patients at high risk of influenza-related complications have shown therapeutic benefits. The data was …
Read More »
[ad_1] ZURICH (Reuters) – Influenza drug baloxavir marboxil significantly sped time to relief for patients highly vulnerable to serious complications, a late-stage clinical trial has shown, Swiss drugmaker Roche said on Thursday. …
Read More »
[ad_1] ZURICH (Reuters) – Baloxavir marboxil, an influenza drug, has significantly relieved patients who are extremely vulnerable to serious complications, a top-of-the-line clinical trial said Thursday, according to Swiss drug maker Roche. …
Read More »